Dr. Steve H. Fung is a neuroradiologist at the Houston Methodist Hospital, Neuroradiology Section Head of Diagnostic Radiology Residency Program, Director of Clinical Functional MRI, Medical Director of MRI Core at the Houston Methodist Research Institute, and Magnetic Resonance Medical Director responsible for MRI safety at the Houston Methodist Hospital. He graduated from the University of Texas at Austin with B.S., Highest Honors in Electrical Engineering and B.S., Highest Honors in Zoology (Neuroscience) with concentrations in mathematics and physics. He obtained his M.D. from Harvard Medical School, Harvard/MIT Division of Health Sciences and Technology. His training includes residency in radiology at the University of Texas Houston/MD Anderson Cancer Center, postdoctoral research fellowship in the Imaging Sciences Training Program at the National Institutes of Health, and clinical fellowship in neuroradiology at the Massachusetts General Hospital. He serves as the primary provider at Houston Methodist for advanced neuroimaging including clinical fMRI, DTI tractography, 3D anatomical modeling, CT/MRI/PET/SPECT fusion, lesion segmentation, MR spectroscopy, quantitative perfusion, CSF flow, and brain regional volumetric analysis. As a member of the Houston Methodist Research Institute, his research interests are in advanced MRI applications that can be applied broadly to a wide spectrum of CNS diseases, including cerebrovascular, neoplastic, and neurodegenerative diseases. Additionally, as Medical Director of the MRI Core, he provides MRI safety guidelines for human studies, guidance in developing MRI protocols including feasibility with available MRI technology, image and data analysis.

-Applying advanced MRI techniques to evaluate diseases of the central nervous system, including brain tumors, cerebrovascular disease/stroke, dementia/neurodegenerative diseases, and epilepsy, to grade severity of disease and predict outcome.

-Using ASL MRI to determine regional variation of cerebral perfusion and cerebrovascular reactivity in disease states and serial changes in perfusion in response to therapeutic intervention.
-Evaluating functional connectivity using task-based and resting state functional MRI in normal and disease states.
-Analyzing tumor microvasculature and modulating the blood brain barrier for enhanced drug delivery.
-Understanding limitations of kinetic models for estimating perfusion and permeability.
-Developing techniques for molecular imaging, controlled drug release, and enhanced drug delivery.